Among individuals with relapsing-remitting MS, intermittent calorie restriction and ketogenic diets reduce metabolomic age.

Among patients with multiple sclerosis, depression or anxiety are associated with being on Medicaid, clinical relapse, and DMT delay.

The U.S. Employee Perspectives on Managing Chronic Conditions in the Workplace poll was conducted Oct. 2 to 16, 2024, and included a nationally representative sample of the 1,010 part-time and ...

Jeanette Tinggaard, Ph.D., from Copenhagen University Hospital in Denmark, and colleagues estimated the cumulative risk for epilepsy after neonatal seizures and identified subpopulations at increased ...

Patients with predominantly cranial vs isolated extracranial GCA phenotypes present with different patterns of arterial involvement on 18F-FDG PET-CT scans.

Serious neurologic complications are uncommon among young children with influenza but occur more often among those with underlying neurologic conditions.

Smoking and high-intensity smoking are associated with cryptogenic ischemic stroke (CIS) among adults aged 18 to 45 years.

Mild cognitive impairment and Alzheimer disease have a low prevalence among newly diagnosed patients with multiple sclerosis.

Cladribine treatment for relapsing multiple sclerosis improves health-related quality of life and preserves cognitive function after 4 years.

For patients transitioning from rituximab to ravulizumab, meningococcal vaccination can be safely done within 6 months after stopping rituximab.

In patients with relapsing MS, the transition to cladribine from natalizumab is a safe and effective option that provides sustained disease stability.

Children with pediatric-onset multiple sclerosis (POMS) have shorter telomeres, suggesting MS may accelerate biological aging.